Blood flow distribution with adrenergic and histaminergic antagonists.
Superficial fibular nerve stimulation (SFNS) causes increased pre- and post-capillary resistances as well as increased capillary permeability in the dog hind paw. These responses indicate possible adrenergic and histaminergic interactions. The distribution of blood flow between capillaries and arteriovenous anastomoses (AVA) may depend on the relative effects of these neural inputs. Right hind paws of anesthetized heparinized dogs were vascularly and neurally isolated and perfused with controlled pressure. Blood flow distribution was calculated from the venous recovery of 85Sr-labeled microspheres (15 microns). The mean transit times of 131I-albumin and 85Sr-labeled microspheres were calculated. The effects of adrenergic and histaminergic antagonists with and without SFNS were determined. Phentolamine blocked the entire response to SFNS. Prazosin attenuated increases in total and AVA resistance. Yohimbine prevented increased total resistance, attenuated the AVA resistance increase, and revealed a decrease in capillary circuit resistance. Pyrilamine attenuated total resistance increase while SFNS increased capillary and AVA resistances. Metiamide had no effect on blood flow distribution with SFNS. The increase in AVA resistance with SFNS apparently resulted from a combination of alpha 1 and alpha 2 receptor stimulation but not histaminergic effects.
Baker
C H
CH
Department of Physiology and Biophysics, College of Medicine, University of South Florida, Tampa 33612.
Davis
D L
DL
Sutton
E T
ET
D000818:Animals; D001163:Arteriovenous Anastomosis / Q000502:physiology; D001783:Blood Flow Velocity / Q000187:drug effects; D002196:Capillaries / Q000502:physiology; D004285:Dogs; D005260:Female; D006614:Hindlimb / Q000294:innervation; D006633:Histamine Antagonists / Q000494:pharmacology*; D008297:Male; D008785:Metiamide / Q000494:pharmacology; D008833:Microcirculation / Q000187:drug effects*; D008863:Microspheres; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011224:Prazosin / Q000494:pharmacology; D011738:Pyrilamine / Q000494:pharmacology; D012039:Regional Blood Flow / Q000187:drug effects; D013326:Strontium Radioisotopes; D013565:Sympatholytics / Q000494:pharmacology*; D015016:Yohimbine / Q000494:pharmacology
D006633:Histamine Antagonists; D013326:Strontium Radioisotopes; D013565:Sympatholytics; D015016:Yohimbine; D008785:Metiamide; D011738:Pyrilamine; D009638:Norepinephrine; D011224:Prazosin; D010646:Phentolamine